Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis

被引:92
作者
Albaugh, V. L. [1 ]
Judson, J. G. [1 ]
She, P. [1 ]
Lang, C. H. [1 ]
Maresca, K. P. [2 ]
Joyal, J. L. [2 ]
Lynch, C. J. [1 ]
机构
[1] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA
[2] Mol Insight Pharmaceut, Cambridge, MA USA
关键词
atypical antipsychotics; insulin resistance; nutrient partitioning; hyperinsulinemic-euglycemic clamp; free fatty acid uptake; lipogenesis; INDUCED WEIGHT-GAIN; ATYPICAL ANTIPSYCHOTICS; INSULIN-RESISTANCE; BODY-WEIGHT; IN-VIVO; INGESTIVE BEHAVIOR; GLUCOSE-UPTAKE; METABOLISM; CLOZAPINE; HYPERGLYCEMIA;
D O I
10.1038/mp.2010.33
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Olanzapine and other atypical antipsychotics cause metabolic side effects leading to obesity and diabetes; although these continue to be an important public health concern, their underlying mechanisms remain elusive. Therefore, an animal model of these side effects was developed in male Sprague-Dawley rats. Chronic administration of olanzapine elevated fasting glucose, impaired glucose and insulin tolerance, increased fat mass but, in contrast to female rats, did not increase body weight or food intake. Acute studies were conducted to delineate the mechanisms responsible for these effects. Olanzapine markedly decreased physical activity without a compensatory decline in food intake. It also acutely elevated fasting glucose and worsened oral glucose and insulin tolerance, suggesting that these effects are adiposity independent. Hyperinsulinemic-euglycemic clamp studies measuring C-14-2-deoxyglucose uptake revealed tissue-specific insulin resistance. Insulin sensitivity was impaired in skeletal muscle, but either unchanged or increased in adipose tissue depots. Consistent with the olanzapine-induced hyperglycemia, there was a tendency for increased C-14-2-deoxyglucose uptake into fat depots of fed rats and, surprisingly, free fatty acid (FFA) uptake into fat depots was elevated approximately twofold. The increased glucose and FFA uptake into adipose tissue was coupled with increased adipose tissue lipogenesis. Finally, olanzapine lowered fasting plasma FFA, and as it had no effect on isoproterenol-stimulated rises in plasma glucose, it blunted isoproterenol-stimulated in vivo lipolysis in fed rats. Collectively, these results suggest that olanzapine exerts several metabolic effects that together favor increased accumulation of fuel into adipose tissue, thereby increasing adiposity. Molecular Psychiatry (2011) 16, 569-581; doi: 10.1038/mp.2010.33; published online 23 March 2010
引用
收藏
页码:569 / 581
页数:13
相关论文
共 48 条
[1]   GLYCOGEN-STORAGE CAPACITY AND DENOVO LIPOGENESIS DURING MASSIVE CARBOHYDRATE OVERFEEDING IN MAN [J].
ACHESON, KJ ;
SCHUTZ, Y ;
BESSARD, T ;
ANANTHARAMAN, K ;
FLATT, JP ;
JEQUIER, E .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 48 (02) :240-247
[2]   NUTRITIONAL INFLUENCES ON LIPOGENESIS AND THERMOGENESIS AFTER A CARBOHYDRATE MEAL [J].
ACHESON, KJ ;
SCHUTZ, Y ;
BESSARD, T ;
RAVUSSIN, E ;
JEQUIER, E ;
FLATT, JP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (01) :E62-E70
[3]   Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease - A placebo-controlled study of olanzapine and risperidone in dogs [J].
Ader, M ;
Kim, SP ;
Catalano, KJ ;
Ionut, V ;
Hucking, K ;
Richey, JM ;
Kabir, M ;
Bergman, RN .
DIABETES, 2005, 54 (03) :862-871
[4]   Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents [J].
Albaugh, Vance L. ;
Henry, Cathy R. ;
Bello, Nicholas T. ;
Hajnal, Andras ;
Lynch, Susan L. ;
Halle, Beth ;
Lynch, Christopher J. .
OBESITY, 2006, 14 (01) :36-51
[5]  
Ananth J, 2004, CURR PHARM DESIGN, V10
[6]   An animal model of antipsychotic-induced weight gain [J].
Arjona, AA ;
Zhang, SX ;
Adamson, B ;
Wurtman, RJ .
BEHAVIOURAL BRAIN RESEARCH, 2004, 152 (01) :121-127
[7]   Fatal olanzapine-induced hyperglycemic ketoacidosis [J].
Avella, J ;
Wetli, CV ;
Wilson, JC ;
Katz, M ;
Hahn, T .
AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY, 2004, 25 (02) :172-175
[8]  
Benvenga MJ, 1997, DRUG DEVELOP RES, V41, P48
[9]   ASSESSMENT OF INSULIN SENSITIVITY INVIVO - A CRITICAL-REVIEW [J].
BERGMAN, RN ;
HOPE, ID ;
YANG, YJ ;
WATANABE, RM ;
MEADOR, MA ;
YOUN, JH ;
ADER, M .
DIABETES-METABOLISM REVIEWS, 1989, 5 (05) :411-429
[10]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911